Victor F. Tapson, MD, Professor of Medicine and Associate Director of Pulmonary Critical Care, and Director of Venous Thromboembolism (VTE) Research at Cedars-Sinai Medical Center in Los Angeles, talks about the use of rivaroxaban in the treatment of VTE, as well as how COVID-19 has affected treatment of his patients.

This is the second part of a two-part interview. Part 1 of this interview can be viewed here.